Initial first-in-human results: CD33-deleted hematopoietic stem and progenitor cells display normal engraftment after hematopoietic cell transplant (HCT) and tolerate post-hct gemtuzumab ozogamicin (GO) without cytopenias Meeting Abstract
| Authors: | Tomlinson, B.; Suh, H. C.; Koura, D.; Koehne, G.; Cho, C.; Bambace, N. M.; Bernard, L.; Shah, N.; Walter, R. B.; DiPersio, J. F.; Perales, M. A.; Loken, M.; Nath, S.; Raffel, G.; Cooper, B. |
| Abstract Title: | Initial first-in-human results: CD33-deleted hematopoietic stem and progenitor cells display normal engraftment after hematopoietic cell transplant (HCT) and tolerate post-hct gemtuzumab ozogamicin (GO) without cytopenias |
| Meeting Title: | 49th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 58 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Apr 23-26 |
| Meeting Location: | Paris, France |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2023-12-01 |
| Start Page: | 274 |
| End Page: | 275 |
| Language: | English |
| ACCESSION: | WOS:001110902800353 |
| PROVIDER: | wos |
| PUBMED: | 37945721 |
| DOI: | 10.1038/s41409-023-02056-7 |
| Notes: | Meeting Abstract: P180 -- Found in section, "Physicians – Poster Session" -- This was a hybrid meeting -- Source: Wos |
